Global Microfluidic Devices Market Overview:
Microfluidics device is a technology that allows the integration of many medical tests on a single chip. It has a several applications in the field of medicine, cell biology research, and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatment. It has become an important technology for integration, miniaturization, industrialization, and parallelization of various tests in the fields of diagnostics, biological research, and drug development. Some of the players profiled in the study are Danaher Corporation (United States), Thermo Fisher Scientific (United States), Agilent Technologies (United States), Fluidigm Microfluidics (United States), Bio-Rad Laboratories, Inc. (United States), Becton, Dickinson and Company (United States), Abbott Laboratories (United States), Cepheid (United States), RainDance Technologies, Inc. (United States), Dolomite Microfluidics (United Kingdom) and Micronit Microtechnologies (Netherlands).
On the basis of geography, the market of Microfluidic Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Industry, the sub-segment i.e. In-vitro diagnostics will boost the Microfluidic Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Material , the sub-segment i.e. Glass will boost the Microfluidic Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increasing R&D Investment in Pharmaceuticals, Life Science Sector
- Rising Demand for Point-of-Care Testing
- Rising Number of Product Innovations
- Strict Regulatory Requirements
- Increasing Demand of Microfluidic Devices in Genomics and Proteomics
- Change in the Material Mix Provides New Opportunities for New Players
- Geometrical and Surface Chemistry Issues
- Standardization of Microfluidic Devices
Key Market Developments:
In Aug 2019, Agilent Technologies, Inc. announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture, and distribution of innovative life science instrumentation.
In May 2018, CN Bio Innovations Limited launched PhysioMimix, a printer-sized device which allows scientist to conduct organ-on-chip studies in their own labs, testing new drugs and chemicals on living human organ models.
Microfluidic Devices Manufcatuees, Microfluidic Devices Suppliers/Distributors, Raw Material Suppliers, Potential Investors, Technology Investors, Research Firm and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Microfluidic Devices market on the basis of product [Glass , Polymer and Silicon] , application [Pharmaceutical and Life Science Research, Clinical and Veterinary Diagnostics, Point of Care Diagnostics, Analytical Devices, Drug Delivery and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Microfluidic Devices market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Microfluidic Devices industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Microfluidic Devices market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.